Morgan Stanley’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34M | Buy |
|
|||||
|
2025
Q1 | $9.49M | Buy |
|
|||||
|
2024
Q4 | $8.17M | Sell |
|
|||||
|
2024
Q3 | $27.7M | Buy |
|
|||||
|
2024
Q2 | $30.9M | Buy |
|
|||||
|
2024
Q1 | $5.86M | Sell |
|
|||||
|
2023
Q4 | $13.7M | Buy |
|
|||||
|
2023
Q3 | $1.56M | Buy |
|
|||||
|
2023
Q2 | $652K | Sell |
|
|||||
|
2023
Q1 | $1.33M | Buy |
|
|||||
|
2022
Q4 | $436K | Buy |
|
|||||
|
2022
Q3 | $376K | Sell |
|
|||||
|
2022
Q2 | $681K | Buy |
|
|||||
|
2022
Q1 | $349K | Buy |
|
|||||
|
2021
Q4 | $214K | Sell |
|
|||||
|
2021
Q3 | $734K | Sell |
|
|||||
|
2021
Q2 | $1.13M | Buy |
|
|||||
|
2021
Q1 | $24K | Sell |
|
|||||
|
2020
Q4 | $310K | Buy |
|
|||||
|
2020
Q3 | $71K | Sell |
|
|||||
|
2020
Q2 | $2.38M | Buy |
|
|||||
|
2020
Q1 | $57K | Sell |
|
|||||
|
2019
Q4 | $935K | Buy |
|
|||||
|
2019
Q3 | $242K | Buy |
|
|||||
|
2019
Q2 | $194K | Sell |
|
|||||
|
2019
Q1 | $920K | Buy |
|
|||||
|
2018
Q4 | $649K | Sell |
|
|||||
|
2018
Q3 | $1.41M | Sell |
|
|||||
|
2018
Q2 | $1.79M | Buy |
|
|||||
|
2018
Q1 | $1.43M | Sell |
|
|||||
|
2017
Q4 | $1.24M | Buy |
|
|||||
|
2017
Q3 | $746K | Buy |
|